Literature DB >> 27084037

Intracellular transport and egress of hepatitis B virus.

Marie-Lise Blondot1, Volker Bruss2, Michael Kann3.   

Abstract

Hepatitis B virus (HBV) replicates its genomic information in the nucleus via transcription and therefore has to deliver its partially double stranded DNA genome into the nucleus. Like other viruses with a nuclear replication phase, HBV genomes are transported inside the viral capsids first through the cytoplasm towards the nuclear envelope. Following the arrival at the nuclear pore, the capsids are transported through, using classical cellular nuclear import pathways. The arrest of nuclear import at the nucleoplasmic side of the nuclear pore is unique, however, and is where the capsids efficiently disassemble leading to genome release. In the latter phase of the infection, newly formed nucleocapsids in the cytosol have to move to budding sites at intracellular membranes carrying the three viral envelope proteins. Capsids containing single stranded nucleic acid are not enveloped, in contrast to empty and double stranded DNA containing capsids. A small linear domain in the large envelope protein and two areas on the capsid surface have been mapped, where point mutations strongly block nucleocapsid envelopment. It is possible that these domains are involved in the envelope--with capsid interactions driving the budding process. Like other enveloped viruses, HBV also uses the cellular endosomal sorting complexes required for transport (ESCRT) machinery for catalyzing budding through the membrane and away from the cytosol.
Copyright © 2016 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Egress; Hepatitis B virus; Intracellular transport

Mesh:

Substances:

Year:  2016        PMID: 27084037     DOI: 10.1016/j.jhep.2016.02.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  35 in total

Review 1.  The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.

Authors:  Ahmed Diab; Adrien Foca; Fabien Zoulim; David Durantel; Ourania Andrisani
Journal:  Antiviral Res       Date:  2017-11-26       Impact factor: 5.970

2.  Hepatitis B Virus Subverts the Autophagy Elongation Complex Atg5-12/16L1 and Does Not Require Atg8/LC3 Lipidation for Viral Maturation.

Authors:  Tatjana Döring; Lisa Zeyen; Christina Bartusch; Reinhild Prange
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 3.  Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.

Authors:  Jennifer J Chang; Neaka Mohtashemi; Debika Bhattacharya
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

4.  Hepatitis B Virus DNA Integration Occurs Early in the Viral Life Cycle in an In Vitro Infection Model via Sodium Taurocholate Cotransporting Polypeptide-Dependent Uptake of Enveloped Virus Particles.

Authors:  Thomas Tu; Magdalena A Budzinska; Florian W R Vondran; Nicholas A Shackel; Stephan Urban
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

5.  New Direct-Acting Antiviral Agents and Immunomodulators for Hepatitis B Virus Infection.

Authors:  Marion G Peters; Stephen Locarnini
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-06

6.  Cellular p32 Is a Critical Regulator of Porcine Circovirus Type 2 Nuclear Egress.

Authors:  Tongtong Wang; Qian Du; Yingying Niu; Xiaohua Zhang; Zhenyu Wang; Xingchen Wu; XueFeng Yang; Xiaomin Zhao; Shan-Lu Liu; Dewen Tong; Yong Huang
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

7.  A putative amphipathic alpha helix in hepatitis B virus small envelope protein plays a critical role in the morphogenesis of subviral particles.

Authors:  Sisi Yang; Zhongliang Shen; Yaoyue Kang; Liren Sun; Usha Viswanathan; Hongying Guo; Tianlun Zhou; Xinghong Dai; Jinhong Chang; Jiming Zhang; Ju-Tao Guo
Journal:  J Virol       Date:  2021-02-03       Impact factor: 5.103

Review 8.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

9.  Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.

Authors:  Thomas Lahlali; Jan Martin Berke; Karen Vergauwen; Adrien Foca; Koen Vandyck; Frederik Pauwels; Fabien Zoulim; David Durantel
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 10.  Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.

Authors:  Usha Viswanathan; Nagraj Mani; Zhanying Hu; Haiqun Ban; Yanming Du; Jin Hu; Jinhong Chang; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2020-08-17       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.